Catherine Mezzacappa, MD, MPH
she/her/hers
Clinical Fellow
Research & Publications
Biography
News
Coauthors
Selected Publications
- Proteomic Panels for Alcohol-Associated Liver Disease: Accurate, but Different Enough From Existing Clinical Tests?Mezzacappa C, Bhat M. Proteomic Panels for Alcohol-Associated Liver Disease: Accurate, but Different Enough From Existing Clinical Tests? Gastroenterology 2023, 165: 1576. PMID: 37683704, DOI: 10.1053/j.gastro.2023.09.002.
- Survival in Unresectable Hepatocellular Carcinoma Treated With a New Immune Checkpoint and Anti-angiogenic Drug CombinationMezzacappa C. Survival in Unresectable Hepatocellular Carcinoma Treated With a New Immune Checkpoint and Anti-angiogenic Drug Combination. Gastroenterology 2023, 166: 350. PMID: 37683705, DOI: 10.1053/j.gastro.2023.09.003.
- Do Polygenic Risk Scores Add to Clinical Data in Predicting Pancreatic Cancer? A Scoping Review.Wang L, Grimshaw A, Mezzacappa C, Rahimi Larki N, Yang Y, Justice A. Do Polygenic Risk Scores Add to Clinical Data in Predicting Pancreatic Cancer? A Scoping Review. Cancer Epidemiology Biomarkers & Prevention 2023, 32: 1490-1497. PMID: 37610426, PMCID: PMC10873036, DOI: 10.1158/1055-9965.epi-23-0468.
- Adherence to Tumor Board Recommendations in the Treatment of Patients with Hepatocellular CarcinomaCao Y, Mezzacappa C, Jaffe A, Strazzabosco M, Taddei T. Adherence to Tumor Board Recommendations in the Treatment of Patients with Hepatocellular Carcinoma. Journal Of Multidisciplinary Healthcare 2023, 16: 1531-1540. PMID: 37283950, PMCID: PMC10239642, DOI: 10.2147/jmdh.s407908.
- Disparities in Access to Endoscopy for Patients With Upper Gastrointestinal Bleeding Presenting to Emergency DepartmentsRodriguez NJ, Zheng N, Mezzacappa C, Canavan M, Laine L, Shung D. Disparities in Access to Endoscopy for Patients With Upper Gastrointestinal Bleeding Presenting to Emergency Departments. Gastroenterology 2022, 164: 1044-1046.e4. PMID: 36228735, PMCID: PMC10083188, DOI: 10.1053/j.gastro.2022.10.001.
- Systems approach to enhance Lynch syndrome diagnosis through tumour testingSingh V, Mezzacappa C, Gershkovich P, Di Giovanna J, Ganzak A, Gibson J, Sinard J, Xicola RM, Llor X. Systems approach to enhance Lynch syndrome diagnosis through tumour testing. Journal Of Medical Genetics 2022, 60: 533-539. PMID: 36115663, PMCID: PMC10020126, DOI: 10.1136/jmg-2022-108770.
- Cancer tracking system improves timeliness of liver cancer care at a Veterans Hospital: A comparison of cohorts before and after implementation of an automated care coordination toolZhang Y, Mezzacappa C, Shen L, Ivatorov A, Petukhova-Greenstein A, Mehta R, Ciarleglio M, Deng Y, Levin W, Steinhardt S, Connery D, Pineau M, Onyiuke I, Taylor C, Rose M, Taddei T. Cancer tracking system improves timeliness of liver cancer care at a Veterans Hospital: A comparison of cohorts before and after implementation of an automated care coordination tool. PLOS Digital Health 2022, 1: e0000080. PMID: 36812575, PMCID: PMC9931271, DOI: 10.1371/journal.pdig.0000080.
- An Uncommon Cause of Coffee Ground Emesis in a Young Woman With Remote Roux-en-Y Gastric BypassMezzacappa C, Hughes ML, Hung KW. An Uncommon Cause of Coffee Ground Emesis in a Young Woman With Remote Roux-en-Y Gastric Bypass. Gastroenterology 2022, 163: e16-e17. PMID: 35490784, DOI: 10.1053/j.gastro.2022.04.032.
- Effect of a cancer tracking system on timeliness of liver cancer care at a Veteran's Hospital.Ivatorov A, Mezzacappa C, Taddei T. Effect of a cancer tracking system on timeliness of liver cancer care at a Veteran's Hospital. Journal Of Clinical Oncology 2022, 40: 406-406. DOI: 10.1200/jco.2022.40.4_suppl.406.
- Colorectal Cancer Risk in Lynch Syndrome: Of Genes and MoreMezzacappa C, Llor X. Colorectal Cancer Risk in Lynch Syndrome: Of Genes and More. Gastroenterology 2021, 162: 1358-1360. PMID: 34863785, DOI: 10.1053/j.gastro.2021.11.032.
- Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failureMezzacappa C, Ravindra NG, Caraballo C, Chouairi F, Miller PE, Clarke JD, Gruen J, Mori M, McCullough M, Mullan C, Geirsson A, Rogers JG, Anwer M, Desai N, Ahmad T. Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure. PLOS ONE 2020, 15: e0242928. PMID: 33270648, PMCID: PMC7714148, DOI: 10.1371/journal.pone.0242928.
- Sex Differences in Patients Receiving Left Ventricular Assist Devices for End-Stage Heart FailureGruen J, Caraballo C, Miller PE, McCullough M, Mezzacappa C, Ravindra N, Mullan CW, Reinhardt SW, Mori M, Velazquez E, Geirsson A, Ahmad T, Desai NR. Sex Differences in Patients Receiving Left Ventricular Assist Devices for End-Stage Heart Failure. JACC Heart Failure 2020, 8: 770-779. PMID: 32653446, DOI: 10.1016/j.jchf.2020.04.015.
- REAL-WORLD VERSUS CLINICAL TRIAL OUTCOMES FROM LVADSMezzacappa C, Ravindra N, Carabello C, Chouairi F, McCullough M, Miller P, Clarke J, Gruen J, Mullan C, Geirsson A, Rogers J, Desai N, Ahmad T. REAL-WORLD VERSUS CLINICAL TRIAL OUTCOMES FROM LVADS. Journal Of The American College Of Cardiology 2020, 75: 771. DOI: 10.1016/s0735-1097(20)31398-x.
- THE IMPACT OF SOCIAL SUPPORT ON OUTCOMES AFTER LEFT VENTRICULAR ASSISTANCE DEVICE (LVAD) IMPLANTATIONLawrence J, Caraballo C, Ravindra N, Miller P, McCullough M, Mezzacappa C, Mullan C, Chouairi F, Desai N, Ahmad T. THE IMPACT OF SOCIAL SUPPORT ON OUTCOMES AFTER LEFT VENTRICULAR ASSISTANCE DEVICE (LVAD) IMPLANTATION. Journal Of The American College Of Cardiology 2020, 75: 818. DOI: 10.1016/s0735-1097(20)31445-5.
- IMPACT OF PREOPERATIVE ATRIAL FIBRILLATION/FLUTTER IN LEFT VENTRICULAR ASSIST DEVICE RECIPIENTSClarke J, Caraballo C, Ravindra N, Miller P, McCullough M, Mezzacappa C, Mullan C, Lawrence J, Chouairi F, Desai N, Freeman J, Ahmad T, Friedman D. IMPACT OF PREOPERATIVE ATRIAL FIBRILLATION/FLUTTER IN LEFT VENTRICULAR ASSIST DEVICE RECIPIENTS. Journal Of The American College Of Cardiology 2020, 75: 982. DOI: 10.1016/s0735-1097(20)31609-0.
- SEX DIFFERENCES IN PATIENTS RECEIVING LEFT VENTRICULAR ASSIST DEVICES FOR END STAGE HEART FAILUREGruen J, Caraballo C, Miller P, McCullough M, Mezzacappa C, Ravindra N, Mullan C, Desai N, Ahmad T. SEX DIFFERENCES IN PATIENTS RECEIVING LEFT VENTRICULAR ASSIST DEVICES FOR END STAGE HEART FAILURE. Journal Of The American College Of Cardiology 2020, 75: 807. DOI: 10.1016/s0735-1097(20)31434-0.
- CLINICAL IMPLICATIONS OF DIABETES AMONG PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICESCaraballo C, Ravindra N, Miller P, McCullough M, Mezzacappa C, Mullan C, Lawrence J, Chouairi F, Desai N, Ahmad T. CLINICAL IMPLICATIONS OF DIABETES AMONG PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES. Journal Of The American College Of Cardiology 2020, 75: 684. DOI: 10.1016/s0735-1097(20)31311-5.
- Neurohormonal Blockade and Clinical Outcomes in Patients With Heart Failure Supported by Left Ventricular Assist DevicesMcCullough M, Caraballo C, Ravindra NG, Miller PE, Mezzacappa C, Levin A, Gruen J, Rodwin B, Reinhardt S, van Dijk D, Ali A, Ahmad T, Desai NR. Neurohormonal Blockade and Clinical Outcomes in Patients With Heart Failure Supported by Left Ventricular Assist Devices. JAMA Cardiology 2020, 5: 175-182. PMID: 31738366, PMCID: PMC6865330, DOI: 10.1001/jamacardio.2019.4965.
- Clinical Outcomes After Left Ventricular Assist Device Implantation in Older Adults An INTERMACS AnalysisCaraballo C, DeFilippis EM, Nakagawa S, Ravindra NG, Miller PE, Mezzacappa C, McCullough M, Gruen J, Levin A, Reinhardt S, Mullan C, Ali A, Maurer MS, Desai NR, Ahmad T, Topkara VK. Clinical Outcomes After Left Ventricular Assist Device Implantation in Older Adults An INTERMACS Analysis. JACC Heart Failure 2019, 7: 1069-1078. PMID: 31779930, DOI: 10.1016/j.jchf.2019.10.004.
- Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart FailureMiller PE, Caraballo C, Ravindra NG, Mezzacappa C, McCullough M, Gruen J, Levin A, Reinhardt S, Ali A, Desai NR, Ahmad T. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure. Circulation Heart Failure 2019, 12: e006369. PMID: 31707800, DOI: 10.1161/circheartfailure.119.006369.